Trx and GSH serve as electron-shuttles, transporting this reducing potential to various enzymes and reactions
J Cancer Ther 5(2):198-207, 2014

the compositions comprise about 0.05 %, about 0.1 %, about 0.2 %, about 0.3 %, about 0.4 %, about 0.5 %, about 0.6 %, about 0.7 %, about 0.8 %, about 0.9 %, about 1.0 %, about 1.1 %, about 1.2 %, about 1.3 %, about 1.4 %, about 1.5 %, about 1.6 %, about 1.7 %, about 1.8 %, about 1.9 %, about 2.0 %, about 2.1 %, about 2.2 %, about 2.3 %, about 2.4 %, about 2.5 %, about 2.6 %, about 2.7 %, about 2.8 %, about 2.9 %, about 3.0 %, about 3.1 %, about 3.2 %, about 3.3 %, about 3.4 %, about 3.5 %, about 3.6 %, about 3.7 %, about 3.8 %, about 3.9 %, about 4.0 %, the compositions comprise at least about 0.05 %, at least about 0.1 %, at least about 0.2 %, at least about 0.3 %, at least about 0.4 %, at least about 0.5 %, at least about 0.6 %, at least about 0.7 %, at least about 0.8 %, at least about 0.9 %, at least about 1.0 %, at least about 1.1 %, at least about 1.2 %, at least about 1.3 %, at least about 1.4 %, at least about 1.5 %, at least about 1.6 %, at least about 1.7 %, at least about 1.8 %, at least about 1.9 %, at least about 2.0 %, at least about 2.1 %, at least about 2.2 %, at least about 2.3 %, at least about 2.4 %, at least about 2.5 %, at least about 2.6 %, at least about 2.7 %, at least about 2.8 %, at least about 2.9 %, at least about 3.0 the compositions comprise about 0.005 % and about 5 % PP2 by weight of the composition

This product is not intended to treat, diagnose, cure or prevent any disease.
Acknowledgements: The study was supported by the Medical University of Lodz (502-03/1-156-04/502-14-339 to HZ, 503/1-156-04/503-11-001 to JF and 502-03/1-156-04/502-14-343 to PM) and National Science Center (2016/21/N/NZ5/01932 to PM)
Paolucci T, Cardarola A, Colonnelli P, et al